15th Annual Gettin’ in the Game Junior National Championship (JNC)

Gettin' in the Game - JNC

More than 111 children and their families representing 62 chapters across the country, traveled to Phoenix, Arizona on September 30 – October 2, 2016 to participate in this annual event.

Attendees learned the fundamentals of baseball, golf, or swimming participated in friendly competition, and connected with their peers. Educational seminars focusing on the importance of physical fitness and other related topics were provided on site.

At the conclusion of the JNC, each child was recognized for his or her participation and the champions were announced

MAKING A SPLASH

To celebrate the 15th Anniversary CSL Behring included SWIMMING as a new activity in the Gettin’ in the Game Junior National Championship.

PROGRAM OVERVIEW

Developed by CSL Behring, the Gettin’ in the Game Junior National Championship (JNC) was the first and currently the only national sports competition designed specifically for the bleeding disorders community. The JNC features accomplished Gettin’ in the Game Athletes, who themselves have been diagnosed with bleeding disorders such as hemophilia and von Willebrand disease.

During the program participants will have the opportunity to:

  • Participate in golf, baseball or swimming activities to learn the fundamentals and enhance their skills in that sport.
  • Learn about the importance of physical fitness in managing a bleeding disorder and receive instructions on proper stretching techniques and good athletic form.
  • Show off their golf, baseball or swimming abilities in a national competition with fellow participants from around the country.
  • Connect and build relationships with fellow members of the bleeding disorders community by sharing their personal experiences with one another.
CSL - 100 Years

CSL Behring

Delivering on promises is what we do at CSL. Starting a century ago, we made a promise to save lives and protect the health of people who were stricken with a range of serious and chronic medical conditions. Today, as a leading global biotherapeutics company, that same promise has never been stronger.

CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and von Willebrand Disease and collaborates and supports patient and biomedical communities by improving access to therapies, advancing scientific knowledge, supporting future medical researchers, and engaging our staff in programs that support patient and local communities.

Coagulation